This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Lemtrada
  • /
  • Comparison of Alemtuzumab and Rebif� Efficacy in M...
Clinical trial

Comparison of Alemtuzumab and Rebif� Efficacy in Multiple Sclerosis, Study One (CARE-MS I)

Read time: 1 mins
Last updated:1st Aug 2007
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest